申请人:FAES FARMA, S.A.
公开号:US20210300922A1
公开(公告)日:2021-09-30
The invention relates to compounds of formula (I):
or pharmaceutically acceptable sails or solvates thereof, to pharmaceutical compositions comprising them and to their use in the treatment and/or prevention of diseases or disorders mediated by histamine H4 receptor.